Brief: Sensei Biotherapeutics posts Q2 basic EPS USD -0.31
03/08/2023 12:32
Aug 3 (Reuters) - Sensei Biotherapeutics Q2 basic EPS USD -0.31. * Q2 operating expenses USD 10.177 million * Q2 income from operations USD -10.177 million * Q2 net income USD -9.386 million
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments